title: Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme.
abstract: Several single institution studies have shown a survival advantage when a stereotactic radiosurgery (SRS) boost followed fractionated external beam radiation (FracRT) in the treatment of glioblastoma (GBM). RTOG 93-05 employed SRS before FracRT and demonstrated no survival benefit. We examined the effect of SRS eligibility before and after FracRT on patient outcome in a group of patients treated with conventional therapy without SRS. From 1998 to 2008, 106 patients with GBM treated definitively at the University of Utah were divided into groups based on eligibility for SRS: ineligible ("Never"), eligible before FracRT ("All Pre"), eligible before FracRT only ("Pre Only"), or eligible before and after FracRT ("Always"). Overall (OS) and progression-free survival (PFS) based on SRS eligibility was assessed. Eleven patients were alive at the time of analysis with a median follow-up of 42.3 months. Median OS for groups "All Pre" (n = 29), "Always" (n = 17), "Pre Only" (n = 12), and "Never" (n = 77) were 13.6, 13.6, 12.4, and 9.2 months, respectively. Of the 29 patients in group "All Pre," 12 (41.4%) were ineligible for SRS following FracRT. PFS did not significantly differ between groups. SRS for GBM can only be of benefit to selected patients with minimal focal postoperative disease. Following FracRT, over a third of initially SRS-eligible patients demonstrated more extensive disease in our experience. It is possible inclusion of such patients in a series of SRS for GBM could mask a benefit in remaining patients. No significant difference in OS or PFS based on SRS-eligibility status was found.
authors.affiliation: Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah School of Medicine, 1950 Circle of Hope, Rm. 1570, Salt Lake City, UT, 581-2396, USA. chris.anker@hci.utah.edu
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Anker
authors.forename: Richard V
authors.initials: RV
authors.lastname: Hymas
authors.forename: Lisa J
authors.initials: LJ
authors.lastname: Hazard
authors.forename: Kenneth M
authors.initials: KM
authors.lastname: Boucher
authors.forename: Randy L
authors.initials: RL
authors.lastname: Jensen
authors.forename: Dennis C
authors.initials: DC
authors.lastname: Shrieve
mesh_terms: D000328:Adult; D000368:Aged; D018572:Disease-Free Survival; D019583:Dose Fractionation, Radiation; D005260:Female; D005500:Follow-Up Studies; D005909:Glioblastoma / Q000601:surgery*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D016634:Radiosurgery / Q000379:methods*; D012189:Retrospective Studies; D015983:Selection Bias; D013997:Time Factors
references.citation: J Natl Cancer Inst. 1993 May 5;85(9):704-10
references.pmid: 8478956
references.citation: Can J Neurol Sci. 1997 May;24(2):110-5
references.pmid: 9164686
references.citation: Int J Radiat Oncol Biol Phys. 1979 Oct;5(10):1725-31
references.pmid: 231022
references.citation: Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):461-8
references.pmid: 7673034
references.citation: Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):842-54
references.pmid: 12377338
references.citation: Cancer Res. 2002 Mar 15;62(6):1915-9
references.pmid: 11912174
references.citation: Can J Neurol Sci. 1997 Nov;24(4):307-12
references.pmid: 9398977
references.citation: J Neurosurg. 1978 Sep;49(3):333-43
references.pmid: 355604
references.citation: N Engl J Med. 2005 Mar 10;352(10):987-96
references.pmid: 15758009
references.citation: Oncology (Williston Park). 1990 Mar;4(3):21-31; discussion 32, 37, 41
references.pmid: 2168729
references.citation: Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):144-50
references.pmid: 17306935
references.citation: N Engl J Med. 1980 Dec 4;303(23):1323-9
references.pmid: 7001230
references.citation: Acta Radiol. 1989 May-Jun;30(3):225-32
references.pmid: 2660886
references.citation: Br J Cancer. 1991 Oct;64(4):769-74
references.pmid: 1654987
references.citation: Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):79-88
references.pmid: 9989517
references.citation: Int J Radiat Oncol Biol Phys. 1992;24(1):55-7
references.pmid: 1512163
references.citation: Neurosurgery. 2002 Jan;50(1):41-6; discussion 46-7
references.pmid: 11844233
references.citation: Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1405-9
references.pmid: 2542195
references.citation: J Clin Oncol. 1993 May;11(5):857-62
references.pmid: 8487050
references.citation: Radiother Oncol. 1991 Feb;20(2):99-110
references.pmid: 1851573
references.citation: Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):517-26
references.pmid: 10802381
references.citation: Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):931-41
references.pmid: 7607967
references.citation: J Clin Oncol. 1990 Jul;8(7):1277-80
references.pmid: 2358840
references.citation: Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):601-6
references.pmid: 1651302
references.citation: Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):614-5; author reply 615-6
references.pmid: 15890607
references.citation: Radiology. 1993 Jan;186(1):45-53
references.pmid: 8380108
references.citation: Neuro Oncol. 2008 Jun;10(3):361-7
references.pmid: 18401015
references.citation: Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):71-7
references.pmid: 11163499
references.citation: Cancer Res. 2001 Mar 15;61(6):2744-50
references.pmid: 11289157
references.citation: Lancet Oncol. 2009 May;10(5):459-66
references.pmid: 19269895
references.citation: Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):511-9
references.pmid: 16168843
references.citation: J Clin Oncol. 2002 Mar 15;20(6):1635-42
references.pmid: 11896114
references.citation: J Neurosurg. 1999 Jan;90(1):72-7
references.pmid: 10413158
references.citation: J Natl Cancer Inst. 1990 Dec 19;82(24):1918-21
references.pmid: 2250312
references.citation: J Neurooncol. 2002 Apr;57(2):151-60
references.pmid: 12125977
references.citation: J Clin Oncol. 1992 Sep;10(9):1379-85
references.pmid: 1325539
references.citation: Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1005-11
references.pmid: 9719109
references.citation: Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1351-8
references.pmid: 11121633
references.citation: Am J Clin Oncol. 2004 Oct;27(5):516-21
references.pmid: 15596923
references.citation: Neurosurgery. 2002 Aug;51(2):343-55; discussion 355-7
references.pmid: 12182772
references.citation: AJNR Am J Neuroradiol. 1985 Jul-Aug;6(4):505-14
references.pmid: 2992257
references.citation: Neurosurgery. 1997 Oct;41(4):776-83; discussion 783-5
references.pmid: 9316038
references.citation: Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1045-53
references.pmid: 8985026
references.citation: Int J Radiat Oncol Biol Phys. 1994 Oct 15;30(3):541-9
references.pmid: 7928484
references.citation: Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):853-60
references.pmid: 15465203